{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T22:14:09Z","timestamp":1785795249346,"version":"3.56.0"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,3,3]]},"DOI":"10.7759\/cureus.35730","type":"journal-article","created":{"date-parts":[[2023,3,3]],"date-time":"2023-03-03T17:38:17Z","timestamp":1677865097000},"source":"Crossref","is-referenced-by-count":2,"title":["Peritoneal Carcinomatosis From Malignant Melanoma After Wide Local Excision of a T1a Lesion: A Case Report"],"prefix":"10.7759","author":[{"given":"Matthew","family":"Hager","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Wegener","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Yon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"The American Society of Clinical Oncology. Melanoma. statistics. (2022). Accessed: March 18, 2022: https:\/\/www.cancer.net\/cancer-types\/melanoma\/statistics."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1001\/archdermatol.2010.2","article-title":"Increased risk of second primary cancers after a diagnosis of melanoma","volume":"146","author":"Bradford PT","year":"2010","unstructured":"Bradford PT, Freedman DM, Goldstein AM, Tucker MA. Increased risk of second primary cancers after a diagnosis of melanoma. Arch Dermatol. 2010, 146:265-72. 10.1001\/archdermatol.2010.2","journal-title":"Arch Dermatol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2018.07.049","article-title":"Peritoneal metastases from extra-abdominal cancer - a population-based study","volume":"44","author":"Flanagan M","year":"2018","unstructured":"Flanagan M, Solon J, Chang KH, et al.. Peritoneal metastases from extra-abdominal cancer - a population-based study. Eur J Surg Oncol. 2018, 44:1811-7. 10.1016\/j.ejso.2018.07.049","journal-title":"Eur J Surg Oncol"},{"key":"ref4","unstructured":"National Comprehensive Cancer Network. Melanoma. cutaneous (version 2.2021). (2021). Accessed: March 18, 2022: https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/cutaneous_melanoma.pdf."},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2013.10.028","article-title":"Patterns of failure and predictors of outcome in cutaneous malignant melanoma of the scalp","volume":"70","author":"Terakedis BE","year":"2014","unstructured":"Terakedis BE, Anker CJ, Leachman SA, et al.. Patterns of failure and predictors of outcome in cutaneous malignant melanoma of the scalp. J Am Acad Dermatol. 2014, 70:435-42. 10.1016\/j.jaad.2013.10.028","journal-title":"J Am Acad Dermatol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1001\/archotol.132.4.370","article-title":"Impact of sentinel node status and other risk factors on the clinical outcome of head and neck melanoma patients","volume":"132","author":"Leong SP","year":"2006","unstructured":"Leong SP, Accortt NA, Essner R, et al.. Impact of sentinel node status and other risk factors on the clinical outcome of head and neck melanoma patients. Arch Otolaryngol Head Neck Surg. 2006, 132:370-3. 10.1001\/archotol.132.4.370","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9610(91)90138-4","article-title":"Experience with 998 cutaneous melanomas of the head and neck over 30 years","volume":"162","author":"O\u2019Brien CJ","year":"1991","unstructured":"O\u2019Brien CJ, Coates AS, Petersen-Schaefer K, Shannon K, Thompson JF, Milton GW, McCarthy WH. Experience with 998 cutaneous melanomas of the head and neck over 30 years. Am J Surg. 1991, 162:310-4. 10.1016\/0002-9610(91)90138-4","journal-title":"Am J Surg"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9610(91)90139-5","article-title":"The prognostic implications of location for scalp melanoma","volume":"162","author":"Shumate CR","year":"1991","unstructured":"Shumate CR, Carlson GW, Giacco GG, Guinee VF, Byers RM. The prognostic implications of location for scalp melanoma. Am J Surg. 1991, 162:315-9. 10.1016\/0002-9610(91)90139-5","journal-title":"Am J Surg"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v19.i41.6979","article-title":"Peritoneal carcinomatosis","volume":"19","author":"Coccolini F","year":"2013","unstructured":"Coccolini F, Gheza F, Lotti M, et al.. Peritoneal carcinomatosis. World J Gastroenterol. 2013, 19:6979-94. 10.3748\/wjg.v19.i41.6979","journal-title":"World J Gastroenterol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.23.4799","article-title":"Final version of 2009 AJCC melanoma staging and classification","volume":"27","author":"Balch CM","year":"2009","unstructured":"Balch CM, Gershenwald JE, Soong SJ, et al.. Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol. 2009, 27:6199-206. 10.1200\/JCO.2009.23.4799","journal-title":"J Clin Oncol"},{"key":"ref11","article-title":"Peritoneal Metastasis","author":"Desai JP","year":"2022","unstructured":"Desai JP, Moustarah F. Peritoneal Metastasis. StatPearls (ed): StatPearls [Internet], Treasure Island (FL); 2022."},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdz011","article-title":"Five-year survival outcomes for patients with advanced melanoma treated with pembrolizumab in KEYNOTE-001","volume":"30","author":"Hamid O","year":"2019","unstructured":"Hamid O, Robert C, Daud A, et al.. Five-year survival outcomes for patients with advanced melanoma treated with pembrolizumab in KEYNOTE-001. Ann Oncol. 2019, 30:582-8. 10.1093\/annonc\/mdz011","journal-title":"Ann Oncol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1910836","article-title":"Five-year survival with combined nivolumab and ipilimumab in advanced melanoma","volume":"381","author":"Larkin J","year":"2019","unstructured":"Larkin J, Chiarion-Sileni V, Gonzalez R, et al.. Five-year survival with combined nivolumab and ipilimumab in advanced melanoma. N Engl J Med. 2019, 381:1535-46. 10.1056\/NEJMoa1910836","journal-title":"N Engl J Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/126866-peritoneal-carcinomatosis-from-malignant-melanoma-after-wide-local-excision-of-a-t1a-lesion-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:59:49Z","timestamp":1707508789000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/126866-peritoneal-carcinomatosis-from-malignant-melanoma-after-wide-local-excision-of-a-t1a-lesion-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,3]]},"references-count":13,"URL":"https:\/\/doi.org\/10.7759\/cureus.35730","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3,3]]}}}